GlassScriptPhysician profile
Ducarmel Augustin
NPI 1154435634
$4,056.16
in general payments reported to CMS, 2019-2025
14 companies · $39.60 in 2025
The $39.60 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,003 · 2020: $264 · 2021: $327 · 2022: $1,331 · 2023: $975 · 2024: $117 · 2025: $39.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,410.10 | 2019-2023 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $971.44 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $446.60 | 2019-2022 | |
| Boston Scientific Corporation | $420.91 | 2019-2024 | Watchman Access System, Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $271.91 | 2022-2023 | |
| Lilly USA, LLC | $175.59 | 2020-2023 | Jardiance, Emgality |
| Procept Biorobotics Corporation | $117.27 | 2023 | Aquabeam Robotic System |
| Gilead Sciences, INC. | $88.87 | 2019 | |
| Biosense Webster, INC. | $39.60 | 2025 | Carto 3, Nuvision Ice Catheter |
| Mission Pharmacal Company | $27.74 | 2020 | |
| Pfizer INC. | $24.93 | 2023 | |
| Abbott Laboratories | $23.75 | 2022 | |
| Horizon Therapeutics Plc | $19.10 | 2023 | Krystexxa |
| Novo Nordisk INC | $18.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ducarmel Augustin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.